SCHEMBL31723152

SCHEMBL31723152

COc1ccc(-c2oc3ccccc3c(=O)c2C(=O)O)cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.72
KMT2A Q03164 6/20 0.72
KDM4E B2RXH2 6/20 0.72
MAPT P10636 5/20 0.72
ALDH1A1 P00352 5/20 0.72
HPGD P15428 4/20 0.72
CYP3A4 P08684 4/20 0.72
HSD17B10 Q99714 3/20 0.72
CASP1 P29466 2/20 0.72
CASP7 P55210 2/20 0.72
TP53 P04637 2/20 0.72
LMNA P02545 1/20 0.72
ABCG2 Q9UNQ0 8/20 0.71
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
ABCB1 P08183 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
GLA P06280 1/20 0.55
THRB P10828 1/20 0.55
MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28425332 1.00 MEN1 (0.72) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9527742 0.88 ABCG2 (0.60) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL28425356 0.86 MAPT (0.60) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL22284778 0.86 MAPT (0.73) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL31723128 0.86 MAPT (0.60) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL31723149 0.86 MAPT (0.73) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL28431125 0.86 ABCG2 (0.73) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL31723172 0.86 ABCG2 (0.73) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL22284795 0.85 CA1 (0.60) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL31723144 0.85 MAPT (0.62) MEN1KMT2AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed